Dr. David Alan Claassen, MD, PhD

  • Iowa City, IA
  • Pediatric hematology and oncology physician
NPI1871892455
Part D claims, 2024
12
Publications
3
MIPS score, 2024
80
Hospital affiliations
1
Industry payments
$82
Practice address
200 Hawkins Drive, Iowa City, IA 52242
Practice phone
Call (319) 356-1616
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Find Dr. Claassen's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. David Alan Claassen is a pediatric hematology and oncology physician in Iowa City, Iowa

Dr. Claassen practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Claassen's NPI, 1871892455, was assigned on March 22, 2011. Dr. Claassen graduated from University of Nebraska College of Medicine in 2011. Dr. Claassen holds Iowa license MD-45319.

NPI and contact details
NPI enumeration date
March 22, 2011
NPI status
Active
Practice phone
(319) 356-1616
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
41
Medical school graduation
2011

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. David Alan Claassen practices at University of Iowa Health Care Medical Center in Iowa City, Iowa

Dr. Claassen's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Source: Dmand AI Affiliation Data

Dr. David Alan Claassen is affiliated with 1 site of care and 1 medical group

Dr. Claassen's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. The medical group on file is Scanlan Center for School Mental Health Clinic.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. David Alan Claassen's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Claassen practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
University of Iowa Health Care Medical CenterAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Claassen practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Iowa and 6.2K+ hospitals, with verified contacts in the same login.

Dr. David Alan Claassen is one of 22 pediatric hematologys and oncology physicians in Iowa

Pediatric hematology-oncology is Dr. Claassen's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dmand AI has Dr. Claassen's licenses on file in 2 states: Iowa and Texas.

Specialties and state licenses

  • Pediatric hematology and oncology, IowaPrimaryLicense MD-45319 · taxonomy 2080P0207X
  • Neonatal-perinatal medicine, TexasLicense Q0619 · taxonomy 2080N0001X

Pediatric hematologys and oncology physicians near Dr. Claassen

Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. David Alan Claassen's patients have a median age of 10

Across all payers, Dmand AI patient panel data puts Dr. Claassen's median patient age at 10, with 60% women.

Dr. Claassen's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 10

Patient panel by sex, all payers

  • Women60%
  • Men39%

Source: Dmand AI Patient Panel Data

Dr. David Alan Claassen wrote 12 Medicare Part D claims in 2024

In 2024, Dr. Claassen wrote 12 Medicare Part D claims. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $6,737 in total drug cost. In 2022, CMS named 13 claims across 1 drug.

Part D claims, 202412
Drugs named by CMS1
Total drug cost$6,737

Dr. Claassen's most prescribed drugs by claims, 2023

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2022 to 2023

  • 2022
  • 2023
Claims for drugs CMS names
2022: 132023: 1115%

Drugs named by CMS: 1 in 2023, 1 in 2022.

See all prescribing by Dr. Claassen

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. David Alan Claassen scored 80 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Claassen for performance year 2024, reported as part of a group.

Dr. Claassen's MIPS scores, performance year 2024

  • 80of 100Final score
  • 75.7of 100Quality
  • 78of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find pediatric hematologys and oncology physicians like Dr. Claassen by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. David Alan Claassen has 3 publications on record

Dmand AI links 3 papers to Dr. Claassen, published from 2018 to 2024. Dr. Claassen's most frequent co-authors are Ahmad Al-Huniti, MD, Jennifer Ann Cox, MD and Jeremie Heath Estepp, MD.

Papers3
Years published2018 to 2024

Dr. Claassen's papers by year, 2018 to 2024

Dr. Claassen's most frequent co-authors

Recent publications by Dr. Claassen

See all 3 publications and co-authors

See who Dr. Claassen researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Claassen works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. David Alan Claassen received $82 in industry payments in 2018

CMS Open Payments shows 1 general payment to Dr. Claassen from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $82.

Companies that paid Dr. Claassen the most, 2018 to 2018

Share is of all general payments to this clinician.

See all payments to Dr. Claassen

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. David Alan Claassen graduated from University of Nebraska College of Medicine

Dr. Claassen graduated from University of Nebraska College of Medicine in 2011.

  1. Medical schoolUniversity of Nebraska College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. David Alan Claassen's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesClinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. David Alan Claassen

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. David Alan Claassen's NPI number?

Dr. David Alan Claassen's NPI number is 1871892455. It was assigned on March 22, 2011, and it is active in the NPI Registry.

What kind of doctor is Dr. David Alan Claassen?

Dr. David Alan Claassen is a pediatric hematology and oncology physician in Iowa City, Iowa. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).

Where does Dr. David Alan Claassen practice?

Dr. Claassen practices at 200 Hawkins Drive, Iowa City, IA 52242. Dr. Claassen's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

What is Dr. David Alan Claassen's office phone number?

The practice phone on file for Dr. Claassen is (319) 356-1616.

What is Dr. David Alan Claassen's medical license number?

Dr. Claassen holds Iowa license MD-45319, one of the licenses on file in 2 states.

Which states has Dr. David Alan Claassen been licensed in?

Dmand AI has state licenses on file for Dr. Claassen in Iowa and Texas.

Which hospitals is Dr. David Alan Claassen affiliated with?

Dr. Claassen practices at University of Iowa Health Care Medical Center in Iowa City, Iowa.

What medical group is Dr. David Alan Claassen part of?

Dr. Claassen is linked to Scanlan Center for School Mental Health Clinic.

What is Dr. David Alan Claassen's MIPS score?

Dr. Claassen's MIPS final score for performance year 2024 is 80 out of 100, reported as part of a group.

Where did Dr. David Alan Claassen go to medical school?

Dr. Claassen graduated from University of Nebraska College of Medicine in 2011.

Show 5 more questionsShow fewer questions

What drugs does Dr. David Alan Claassen prescribe most?

In 2023 Medicare Part D data, Dr. Claassen's most prescribed drugs by claims were Eliquis.

Has Dr. David Alan Claassen received payments from drug or device companies?

CMS Open Payments shows $82 in general payments to Dr. Claassen from 1 company from 2018 to 2018. The largest total came from Genentech, Inc.

How long has Dr. David Alan Claassen been practicing?

Dr. Claassen graduated from medical school in 2011, 15 years ago.

Does Dr. David Alan Claassen do research?

Dmand AI links 3 publications to Dr. Claassen, published from 2018 to 2024.

Who does Dr. David Alan Claassen publish with?

Dr. Claassen's most frequent co-authors are Ahmad Al-Huniti, MD (1 shared paper), Jennifer Ann Cox, MD (1 shared paper) and Jeremie Heath Estepp, MD (1 shared paper).

Selling to pediatric hematology-oncology practices?

See pediatric hematologys and oncology physicians in Iowa by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)